Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Nouscom raises €12 million for new vaccines

Country: Switzerland

Nouscom SA, a new developer of cancer vaccines raised €12 million in a Series A financing round earlier this month to support the development of a portfolio of products based on oncolytic viruses and viral vectors. The company is based in Basel, Switzerland.

Read more

Two new HCV drugs endorsed

Country: United Kingdom

The European Medicines Agency has given positive opinions to two new combination drugs to treat chronic hepatitis C virus (HCV) infection, both of which directly target proteins that cause the virus to replicate in humans.

Read more

FDA rejects AstraZeneca hyperkalaemia drug

Country: United States

Read more

Deep-brain stimulation device gets financing

Country: Switzerland

Read more

Shire shareholders agree deal with Baxalta

Country: Ireland

Read more

New insight into Alzheimer’s disease

Country: United States

Read more

UK diagnostics firm in share placement

Country: United Kingdom

Read more

Sanofi seeks to remove Medivation board

Country: France

Read more

MorphoSys joins forces with MD Anderson

Country: Germany

Read more

New technology advisory board at Silence Therapeutics

Country: United Kingdom

Read more

Genentech extends alliance with Evotec

Country: Germany

Read more

Sanofi loses three senior executives

Country: France

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

Why industry is investing in bispecific molecules

BispecificApproachMay2016.pdf

Highlights of the May 2016 MedNous issue

The May 2016 MedNous features:

Latest Mednous cover
  • Oncology Development
    The bispecific approach attracts more followers
  • Drug Development
    European biotechs succeed without partners
    By Robin Davison
  • Commentary
    Good deals getting harder for Pharma
    By Martin Gouldstone
  • Regenerative Medicine
    Oxford startup attracts scientific elite
  • Company News
    Argenx lures AbbVie with preclinical antibody

The latest MedNous journal. Subscribe to download.